USD 1.7
(13.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2022 | 56.21 Million USD | 1835.81% |
2021 | 2.9 Million USD | -90.02% |
2020 | 29.09 Million USD | -13.3% |
2019 | 33.55 Million USD | -12.05% |
2018 | 38.15 Million USD | -11.07% |
2017 | 42.9 Million USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q2 | 61.89 Million USD | -10.07% |
2023 Q1 | 68.82 Million USD | 22.44% |
2022 Q4 | 56.21 Million USD | 112.69% |
2022 Q2 | 30.27 Million USD | 1081.19% |
2022 Q3 | 26.43 Million USD | -12.69% |
2022 FY | 56.21 Million USD | 1835.81% |
2022 Q1 | 2.56 Million USD | -11.74% |
2021 Q4 | 2.9 Million USD | -87.11% |
2021 Q1 | 26.91 Million USD | -7.48% |
2021 FY | 2.9 Million USD | -90.02% |
2021 Q3 | 22.53 Million USD | -8.87% |
2021 Q2 | 24.73 Million USD | -8.12% |
2020 Q3 | 29.86 Million USD | -7.44% |
2020 Q1 | 34.23 Million USD | 2.02% |
2020 Q2 | 32.26 Million USD | -5.77% |
2020 Q4 | 29.09 Million USD | -2.57% |
2020 FY | 29.09 Million USD | -13.3% |
2019 Q3 | 35.68 Million USD | -4.59% |
2019 FY | 33.55 Million USD | -12.05% |
2019 Q4 | 33.55 Million USD | -5.97% |
2019 Q2 | 37.4 Million USD | 1.09% |
2019 Q1 | 36.99 Million USD | -3.03% |
2018 Q2 | 40.46 Million USD | -2.78% |
2018 Q1 | 41.62 Million USD | -2.99% |
2018 FY | 38.15 Million USD | -11.07% |
2018 Q4 | 38.15 Million USD | -2.94% |
2018 Q3 | 39.31 Million USD | -2.86% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | 43.93 Million USD | 0.0% |
2017 Q4 | 42.9 Million USD | -2.35% |
2017 FY | 42.9 Million USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
ANI Pharmaceuticals, Inc. | 309.66 Million USD | 81.846% |
Aquestive Therapeutics, Inc. | 91.07 Million USD | 38.276% |
Collegium Pharmaceutical, Inc. | 489.96 Million USD | 88.526% |
Cosmos Health Inc. | 3.03 Million USD | -1752.049% |
Dynavax Technologies Corporation | 252.41 Million USD | 77.729% |
Intra-Cellular Therapies, Inc. | 13.32 Million USD | -321.852% |
Pacira BioSciences, Inc. | 513.79 Million USD | 89.059% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -10329.007% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -10329.007% |
SCYNEXIS, Inc. | 12.15 Million USD | -362.341% |
Safety Shot Inc | 304.9 Thousand USD | -18337.097% |
China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -47894.946% |
Alpha Teknova, Inc. | 13.25 Million USD | -324.24% |
Bright Green Corporation | 201.78 Thousand USD | -27759.631% |
Esperion Therapeutics, Inc. | 501.54 Million USD | 88.791% |
Embecta Corp. | 1.62 Billion USD | 96.541% |
PainReform Ltd. | 30 Thousand USD | -187286.667% |
Journey Medical Corporation | 14.62 Million USD | -284.462% |
Procaps Group, S.A. | 28.41 Million USD | -97.874% |
Theratechnologies Inc. | 51.26 Million USD | -9.666% |
Harrow Health, Inc. | 183.17 Million USD | 69.31% |
Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -64516.092% |
Biofrontera Inc. | 804 Thousand USD | -6892.04% |
DURECT Corporation | 2.7 Million USD | -1980.533% |
Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -69.346% |
Cronos Group Inc. | 1.55 Million USD | -3505.901% |
OptiNose, Inc. | 611 Thousand USD | -9100.655% |
Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 88.719% |
Kala Pharmaceuticals, Inc. | 34.19 Million USD | -64.422% |
RedHill Biopharma Ltd. | 455 Thousand USD | -12255.165% |
Organogenesis Holdings Inc. | 60.74 Million USD | 7.456% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -339.732% |
Radius Health, Inc. | 339.66 Million USD | 83.45% |
Universe Pharmaceuticals INC | - USD | -Infinity% |
ProPhase Labs, Inc. | 10.25 Million USD | -448.021% |
Phibro Animal Health Corporation | 458.28 Million USD | 87.734% |
Procaps Group S.A. | 28.41 Million USD | -97.874% |
Alvotech | 1.02 Billion USD | 94.53% |
TherapeuticsMD, Inc. | 6.53 Million USD | -760.625% |
Viatris Inc. | 16.18 Billion USD | 99.653% |
Rockwell Medical, Inc. | 8.29 Million USD | -577.873% |
Aytu BioPharma, Inc. | 10.87 Million USD | -416.834% |
SIGA Technologies, Inc. | 335.99 Thousand USD | -16631.401% |
Tilray Brands, Inc. | 287.93 Million USD | 80.476% |
Lifecore Biomedical, Inc. | 120.51 Million USD | 53.352% |
Shineco, Inc. | 10.01 Million USD | -461.187% |
PetIQ, Inc. | 437.82 Million USD | 87.16% |
Regencell Bioscience Holdings Limited | - USD | -Infinity% |
Incannex Healthcare Limited | 210 Thousand USD | -26669.524% |
Neurocrine Biosciences, Inc. | 258.3 Million USD | 78.236% |
Alimera Sciences, Inc. | 64.48 Million USD | 12.829% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 38.51 Million USD | -45.963% |
Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -41514.047% |
Petros Pharmaceuticals, Inc. | 6.85 Million USD | -719.79% |
Clever Leaves Holdings Inc. | 720 Thousand USD | -7707.778% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -249926.686% |
Avadel Pharmaceuticals plc | 32.75 Million USD | -71.6% |
Hempacco Co., Inc. | 5.93 Million USD | -847.833% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 1.02 Billion USD | 94.53% |
Lantheus Holdings, Inc. | 616.12 Million USD | 90.876% |
Currenc Group, Inc. | 2.5 Million USD | -2142.385% |
Kamada Ltd. | 7.43 Million USD | -655.795% |
Indivior PLC | 235.66 Million USD | 76.146% |
Evoke Pharma, Inc. | 5 Million USD | -1024.32% |
Flora Growth Corp. | 942 Thousand USD | -5867.728% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -249926.686% |
Evolus, Inc. | 120.35 Million USD | 53.293% |
HUTCHMED (China) Limited | 48.18 Million USD | -16.657% |
Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 90.459% |
Akanda Corp. | 2.49 Million USD | -2151.202% |